Coley Pharmaceutical Group's Series E Round

Coley Pharmaceutical Group raised a round of funding on September 08, 2003.

Coley Pharmaceutical Group was engaged in the research and development of Toll-like receptor drugs to modulate the immune system for treating cancer, infectious diseases and asthma/allergy.…

Articles about Coley Pharmaceutical Group's Series E Round: